Oramed Pharmaceuticals Inc

ORMP NASDAQ Santé & Biotech États-Unis US68403P2039
4.54 $
3.18 %

Oramed Pharmaceuticals développe des formulations orales de médicaments traditionnellement administrés par injection, telles que l'insuline.

Performance & Momentum

6 Months 92.42 %
1 Year 94.99 %
3 Years 49.74 %
5 Years 57.41 %

Similar stocks to Oramed Pharmaceuticals Inc

Anantys Community

Be the first to share your analysis on Oramed Pharmaceuticals Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases